Search Results - "MA, SHENGLIN"

The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma by Zhang, Hongfang, Si, Jingxing, Yue, Jing, Ma, Shenglin

“…Esophageal squamous cell carcinoma (ESCC) is one of most lethal malignancies with high aggressive potential in the world. Radiotherapy is used as one curative…”
Get full text

Finger-inspired rigid-soft hybrid tactile sensor with superior sensitivity at high frequency by Zhang, Jinhui, Yao, Haimin, Mo, Jiaying, Chen, Songyue, Xie, Yu, Ma, Shenglin, Chen, Rui, Luo, Tao, Ling, Weisong, Qin, Lifeng, Wang, Zuankai, Zhou, Wei

“…Among kinds of flexible tactile sensors, piezoelectric tactile sensor has the advantage of fast response for dynamic force detection. However, it suffers from…”
Get full text

Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients by Hu, Hong, Yao, Xiajuan, Xie, Xiangcheng, Wu, Xia, Zheng, Chuanming, Xia, Wenkai, Ma, Shenglin

“…Background Emerging evidences indicate that inflammation plays a crucial role in carcinogenesis and tumor progression. Inflammatory response biomarkers are…”
Get full text

Advances in CT features and radiomics of checkpoint inhibitor-related pneumonitis: A short review by Huang, Jie, Chen, Xueqin, Xia, Bing, Ma, Shenglin

“…Checkpoint inhibitor-related pneumonitis (CIP) is a complication of immunotherapy for malignant tumors that severely limits the treatment cycles as well as…”
Get full text

Docetaxel-Loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer by Feng, Xing, Xiong, Xiaoling, Ma, Shenglin

“…Nowadays, non-small cell lung cancer (NSCLC) is threatening the health of all mankind. Although many progresses on treatment of lung cancer have been achieved…”
Get full text

SEPT9: From pan-cancer to lung squamous cell carcinoma by Wang, Wenwen, Zhang, Xiaochen, Gui, Ping, Zou, Qizhen, Nie, Yuzhou, Ma, Shenglin, Zhang, Shirong

“…SEPT9 is a pivotal cytoskeletal GTPase that regulates diverse biological processes encompassing mitosis and cytokinesis. While previous studies have implicated…”
Get full text

Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals by Deng, Gang, Wang, Ronghao, Sun, Yin, Huang, Chi-Ping, Yeh, Shuyuan, You, Bosen, Feng, Changyong, Li, Gonghui, Ma, Shenglin, Chang, Chawnshang

“…Androgen-deprivation therapy (ADT) via targeting androgens/androgen receptor (AR) signals may suppress cell proliferation in both prostate cancer (PCa) and…”
Get full text

Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report by Zhu, Lucheng, Ma, Shenglin, Xia, Bing

“…Little is known about the efficacy of alectinib for papillary thyroid cancer with STRN-ALK fusion. A 64-year-old female presented with metastatic papillary…”
Get full text

Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer by Feng, Xing, Xiong, Xiaoling, Ma, Shenglin

Get full text

TSV‐based common‐mode noise‐suppressing filter design and implementation by Li, Zhensong, Liu, Huan, Sun, Yunheng, Yang, Yang, Miao, Min, Ma, Shenglin, Jin, Yufeng

“…A through‐silicon via (TSV)‐based, common‐mode, noise‐suppressing filter (TSV‐CMF) with the silicon interposer process is proposed to improve the…”
Get full text

HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport by Luo, Peihua, Xu, Zhifei, Li, Guanqun, Yan, Hao, Zhu, Yi, Zhu, Hong, Ma, Shenglin, Yang, Bo, He, Qiaojun

“…Sunitinib, a multikinase inhibitor approved for a number of cancer indications has a low response rate. Identifying mechanisms of resistance could lead to…”
Get full text

Downregulation of breast cancer resistance protein by long-term fractionated radiotherapy sensitizes lung adenocarcinoma to SN-38 by Wang, Yuqing, Huang, Jie, Wu, Qiong, Zhang, Jingjing, Ma, Zhiyuan, Ma, Shenglin, Zhang, Shirong

“…Summary Chemotherapy is usually the subsequent treatment for non-small cell lung cancer patients with acquired radioresistance after long-term fractionated…”
Get full text

In flow-based technologies: A new paradigm for the synthesis and processing of covalent-organic frameworks by Martinez-Bulit, Pablo, Sorrenti, Alessandro, Rodriguez San Miguel, David, Mattera, Michele, Belce, Yonca, Xia, Yanming, Ma, Shenglin, Huang, Mu-Hua, Pané, Salvador, Puigmartí-Luis, Josep

“…•Microfluidics can be used for up-scaled processing of covalent-organic frameworks.•Microfluidics offers an exquisite control over mixing regimes.•Mixing…”
Get full text

Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies by Valentin, Marie-Anne, Ma, Shenglin, Zhao, An, Legay, François, Avrameas, Alexandre

“…Biomarkers have emerged as an important tool to optimize the benefit/risk ratio of therapeutics. The scientific impact of biomarker studies is directly related…”
Get full text

Cytoplasmic DNAs: Sources, sensing, and roles in the development of lung inflammatory diseases and cancer by He, Xintong, Sun, Ye, Lu, Jianzhang, Naz, Faiza, Ma, Shenglin, Liu, Jian

“…Cytoplasmic DNA is emerging as a pivotal contributor to the pathogenesis of inflammatory diseases and cancer, such as COVID-19 and lung carcinoma. However, the…”
Get full text

DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues by Zhang, Shirong, He, Shutao, Zhu, Xin, Wang, Yunfei, Xie, Qionghuan, Song, Xianrang, Xu, Chunwei, Wang, Wenxian, Xing, Ligang, Xia, Chengqing, Wang, Qian, Li, Wenfeng, Zhang, Xiaochen, Yu, Jinming, Ma, Shenglin, Shi, Jiantao, Gu, Hongcang

“…Identifying the primary site of metastatic cancer is critical to guiding the subsequent treatment. Approximately 3–9% of metastatic patients are diagnosed with…”
Get full text

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial by Zhang, Li, Prof, Ma, Shenglin, MD, Song, Xiangqun, MSc, Han, Baohui, MD, Cheng, Ying, MSc, Huang, Cheng, MD, Yang, Shujun, MD, Liu, Xiaoqing, MD, Liu, Yunpeng, MD, Lu, Shun, MD, Wang, Jie, MD, Zhang, Shucai, MD, Zhou, Caicun, MD, Zhang, Xiangwei, MD, Hayashi, Nobuya, BA, Wang, Mengzhao, MD

“…Summary Background Maintenance treatment of patients with advanced non-small-cell lung cancer (NSCLC) without disease progression after first-line chemotherapy…”
Get full text

Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer by Zhang, Shirong, Zhang, Xiaochen, Lei, Wei, Liang, Jiafeng, Xu, Yasi, Liu, Hailiang, Ma, Shenglin

“…Lung cancer is the second most common cancer with an extremely poor overall survival rate. Post-transcriptional regulation of gene expression play many…”
Get full text

s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamide by Luo, Peihua, Yan, Hao, Chen, Xueqin, Zhang, Ying, Zhao, Ziying, Cao, Ji, Zhu, Yi, Du, Jiangxia, Xu, Zhifei, Zhang, Xiaochen, Zeng, Su, Yang, Bo, Ma, Shenglin, He, Qiaojun

“…Hand–foot skin reaction (HFSR), among the most significant adverse effects of sorafenib, has been limiting the clinical benefits of this frontline drug in…”
Get full text

Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era by Huang, Jie, Xu, Ying, Chen, Yidan, Shen, Juan, Qiu, Yao, Li, Xin, Chen, Xueqin, Ma, Shenglin

Get full text